CETUXIMAB
UNII PQX0D8J21J

Substance Identification & Data

This profile provides standardized clinical and technical data for Cetuximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PQX0D8J21J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 205923-56-4 and the RxNorm Concept ID (RxCUI) 318341. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PQX0D8J21J

CAS Registry Number

205923-56-4

RxNorm Concept ID

318341

Detailed Substance Profile

Preferred Name

CETUXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

PQX0D8J21J

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C1723

National Cancer Institute reference terminology for clinical and research data.

INN ID

7906

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KK-51

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cetuximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CETUXIMAB

CETUXIMAB BETA

Common Names & Synonyms

CETUXIMAB (GENETICAL RECOMBINATION)

CETUXIMAB (GENETICAL RECOMBINATION) [JAN]

CETUXIMAB [EMA EPAR]

CETUXIMAB [HSDB]

CETUXIMAB [INN]

CETUXIMAB [JAN]

CETUXIMAB [MART.]

CETUXIMAB [MI]

CETUXIMAB [PURPLE BOOK CDER]

CETUXIMAB [USAN]

CETUXIMAB [VANDF]

CETUXIMAB [WHO-DD]

CETUXIMAB BETA [INN]

CETUXIMAB BETA [WHO-DD]

CETUXIMAB BIOSIMILAR (ABP-494)

CETUXIMAB BIOSIMILAR (SHANGHAI ZHANGJIANG)

CMAB-009 (BIOSIMILAR OF CETUXIMAB)

EXTRACELLULAR DOMAIN HUMAN EGFR BINDING RECOMBINANT, HUMAN/MOUSE CHIMERIC MONOCLONAL ANTIBODY

FV REGIONS OF MURINE ANTI-EGFR ANTIBODY WITH HUMAN IGG1 HEAVY AND KAPPA LIGHT CHAIN CONSTANT REGIONS, MW 152000

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER